are some people resistant to glp 1 One in 10 may have resistance GLP-1 diabetes drugs 🧬 NEW STANFORD STUDY: 1

GLP-1R agonist liraglutide attenuates inflammatory reaction and neuronal apoptosis and reduces early brain injury after subarachnoid hemorrhage in rats

BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide that operates through nitric oxide system modulation, growth factor upregulation (VEGF, FGF, EGF), and FAK-paxillin pathway activation

In these cultures, cells seem to have lost the typical neuronal phenotype and characteristic neuritic processes of SH-SY5Y cells, became rounded, and, thereafter, lost their viability

Glia 69 , 15831604 (2021)

Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health. The FDAs decision is largely based on data from the SELECT trial, which included more than 17,000 overweight or obese patients with a baseline age of 45 years old